P28gst (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
96 | Crohn disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02281916 (ClinicalTrials.gov) | March 2014 | 28/10/2014 | Safety Study of P28GST Treatment in Crohn's Disease Patients | Safety Study of P28GST Treatment in Crohn's Disease Patients, a Multicenter Phase 2 Clinical Trial | Crohn's Ileocolitis | Drug: P28GST | University Hospital, Lille | National Research Agency, France;Institut National de la Santé Et de la Recherche Médicale, France | Completed | 18 Years | N/A | All | 10 | Phase 2 | France |